AGER and central nervous system cancer: In glioma, high-mobility group box 1 (HMGB1) derived from NETs binds to receptor for advanced glycation end products (RAGE) expressed in glioma tissue, activating the NF-κB signalling pathway to promote IL-8 secretion, which promotes neutrophil infiltration (92).